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Abstract
Background: γδ T cells have an important immunoregulatory and effector function through
cytokine release. They are involved in the responses to Gram-negative bacterium and in protection
of lung epithelium integrity. On the other hand, they have been implicated in airway inflammation.
Methods: The aim of the present work was to study intracytoplasmic IL-2, IL-4, IFN-γ and TNF-
α production by γδ and αβ T lymphocytes from cystic fibrosis patients and healthy donors in
response to Pseudomonas aeruginosa (PA). Flow cytometric detection was performed after
peripheral blood mononuclear cells (PBMC) culture with a cytosolic extract from PA and
restimulation with phorbol ester plus ionomycine. Proliferative responses, activation markers and
receptor usage of γδ T cells were also evaluated.
Results: The highest production of cytokine was of TNF-α and IFN-γ, γδ being better producers
than αβ. No differences were found between patients and controls. The Vγ9δ2 subset of γδ T cells
was preferentially expanded. CD25 and CD45RO expression by the αβ T subset and PBMC
proliferative response to PA were defective in cystic fibrosis lymphocytes.
Conclusion: Our results support the hypothesis that γδ T lymphocytes play an important role in
the immune response to PA and in the chronic inflammatory lung reaction in cystic fibrosis patients.
They do not confirm the involvement of a supressed Th1 cytokine response in the pathogenesis of
this disease.
Introduction
Cystic Fibrosis (CF) is the most common serious reces-
sively inherited disease among Caucasians [1]. It is associ-
ated with impaired mucociliary clearance, abnormally
thick mucus, chronic infections and lung inflammation.
Most of CF patients are chronically colonized by bacteria
such as Pseudomonas aeruginosa (PA) in their respiratory
tract, this microorganism being their main cause of
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morbidity and mortality [2]. A single major mutation
(∆F508) in the Cystic Fibrosis Transmembrane Conduct-
ance Regulator (CFTR) gene is responsible for 70% of CF
cases, but over 800 mutations have been identified. CFTR
is an anion channel and it negatively regulates the amilo-
ride-sensitive epithelial Na channel [3]. Individuals, how-
ever, with mutations that affect apical epithelial Na+
channel function do not have infectious lung disease. In
primary ciliary diskinesia, the absence of mucociliary
clearance results in recurrent lung infections, but the diag-
nosis is often delayed until adulthood and PA coloniza-
tion is absent. All this evidence suggests that other factors
are involved in CF.
CFTR was found in CD4-positive T cells and a Cl- channel
function, similar to that regulated by CFTR in epithelial
cells, was detected in these lymphocytes. This function
was defective in CF patients [4]. Therefore CFTR muta-
tions could affect immunocompetent or accessory cells. In
fact immunoregulatory defects in CF patients have been
described and include reduced supressor and helper T cell
activity [5].
Most of T cells bear the heterodimeric αβ antigen receptor
but a relatively small subset express two different rear-
ranging genes, γ and δ. About 5% of human peripheral
blood lymphocytes are γδ T lymphocytes, but they are
preferentially localized in epithelial and mucosal tissues.
Protective response to pulmonary injury requires γδ T
lymphocytes [6,7]. In previous reports we described an
increased percentage of γδ T cells in peripheral blood of
CF patients [8] and we showed, in healthy individuals, a
preferential "in vitro" proliferation of these cells in
response to PA cytosolic non-peptidic phosphorilated
antigens [9]. γδ T cells have been described as an immu-
noregulatory subset [10,11] and their cytotoxic activity
has been associated with some diseases [12,13]. Specific
changes in γδ T receptor genes usage related to function
have been described in patients with pulmonary tubercu-
losis [14].
In the last few years attention has been focused on the role
of cell-mediated immunity in host defense against bron-
chopulmonary infection with Gram-negative bacterium.
A correlation between poor lung function and elevated
bacteria-specific antibody level in CF patients and animal
models was demonstrated [15]. Furthermore, protective
immune responses in animal models mimicking CF were
cell-mediated [15–17]. The mechanisms by which T cells
protect the lung are not completely known but it has been
demonstrated that they activate the local phagocytic
response through cytokine release [18]. γδ T cells have
been described as important inducers of TNF-α produc-
tion by LPS-stimulated macrophages [19]. In addition,
mice depleted of these lymphocytes showed exaggerated
bacterial growth after E. coli infection [20]. Recent "in
vivo" experiments have demonstrated that T lymphocytes
expressing Vγ9 and Vδ2 genes are mediators of resistance
against extracellular gram-negative and positive bacteria
[21].
PA has a biofilm mode of growth that could be regarded
as a protective multicellular survival strategy, resembling
intracellular bacteria such as mycobacteria. Th1-type
cytokines, as IFN-γ and TNF-α, are responsible for a good
immune response to intracellular bacteria; in contrast
Th2-type cytokines, as IL-4, induce antibody production
by B lymphocytes [22]. Production of Th1 cytokines by
CD4-positive lymphocytes has been suggested to be
impaired in CF [17,23].
γδ T cells are a Th1-type cytokines source [24,25] and their
role in the "in vivo" mycobacteria clearance in macaques
has been recently demonstrated [26]. A defect in γδ T lym-
phocytes activation or a bias in their cytokine secretion in
response to PA could contribute to the chronic coloniza-
tion by this bacterium. Alternatively chronic γδ T cells acti-
vation could determine a local persistent inflammation in
the lung.
The aim of the current work was to assess the "in vitro"
response of αβ and γδ T lymphocytes from peripheral
blood of healthy controls and CF patients to cytosolic
antigens from PA. To estimate this response we evaluated
two surface markers: CD25, that corresponds to the IL-2
receptor  α-chain and CD45RO, a putative memory
marker. CD25 expression by T lymphocytes correlates
with proliferative responses to antigens and mitogens and
has been described as more sensitive than others markers,
as CD69, to minor subpopulations responses [27].
CD45RO is expressed by T cells after antigen contact and
further antigenic stimulus, at tissue level, commit
CD45RO-positive cells to an effector function [28]. This
marker is then expressed by both memory and effector T
cells.
To assess the type of cytokines secreted in response to PA,
intracytoplasmic IL-4, IFN-γ, TNF-α and IL-2 production
from αβ and γδ T cells was determined by three color flow
cytometry. Phenotypic characteristics of the expanded γδ T
subpopulation and PBMC proliferative activity were also
evaluated.
Materials and Methods
Donors
14 clinically stable outpatients with Cystic fibrosis (8
males and 6 females), age range: 8–29 years (CFw group)
and 17 sex/age matched healthy controls, were studied.
All CF patients had diagnosis confirmed by pilocarpineRespiratory Research 2003, 4 http://respiratory-research.com/content/4/1/9
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iontophoresis sweat test; 5 patients were homozygous for
the  ∆F508 mutation and the remainder were hetero-
zygous for this mutation.
Patients were not receiving systemic corticosteroids and
their treatment included pancreatic enzymes, vitamins
and, in some cases, antibiotic therapy and sympathicomi-
metics. Patients chronically colonized by PA received
cycles of an antipseudomonal penicillin and an aminogly-
coside, oral or intravenous, depending on the antibio-
gram. Two DMID cases were on insulin therapy.
The clinical severity of the disease was estimated using the
Schwachman score (SC). A SC from 41 to 55 corresponds
to moderate severity, from 56 to 70 to slight severity, from
71 to 85 to good status and from 86 to 100 to excellent
status. In our patients, SC ranged from 55 to 95 (Table 1).
PA was detected, by sputum culture, in 9 patients, all of
them chronically colonized by PA (CFp group). Four
patients were free of PA infection at the moment of the
study (CFn group), 3 of these have always been free of PA
and 1 was colonized by PA until two years before the
study and from this date he has been PA-negative. One
patient has always been PA-positive except for a year that
included the blood extraction data. This last patient was
included in the whole (CFw) group but not in the CFp or
in the CFn group. Genetic, clinical and infectious charac-
teristics of the patients are depicted in Table 1.
The study was approved by the Hospital ethical commit-
tee and informed consent was obtained from participants.
Activation kinetics and phenotypic studies
Heparinized peripheral blood was obtained from patients
and controls. Peripheral blood mononuclear cells
(PBMC) were isolated by Ficoll-Hypaque and cultured in
RPMI-1640 supplemented with 10% heat-inactivated
autologous serum, at 37°C, 5% CO2 in air. Heat-treated
cytosolic fraction from PA (PAc) was obtained from a spu-
tum isolated strain as already described [9]. Briefly, we
cultured the isolated bacteria in liquid media and then
washed and heat-treated them at 120°C for 20 min.
Lysates were prepared by passage through a French press
and the supernatants obtained after centrifugation (7840
×  g). Cytosolic antigens (PAc), that were the main PA
stimulatory fraction to γδ T cells [9], were obtained by
lysates ultracentrifugation (80000 × g for 45 min). PAc
was added to PBMC cultures at 50 µg/ml.
CD25 and CD45RO expression by αβ and γδ T cells was
evaluated by three-color flow cytometry before and after
4, 6 and 8 days of culture. We chose these days of culture
because T lymphocytes stimulated with antigen or
mitogen show a peak of CD25 and CD45RO expression
between 4 and 8 days of culture [27,29].
Cells were acquired and analysed on a FACScalibur
cytometer, using CellQuest software, Becton-Dickinson,
Mountain View, CA, USA (BD). Anti-CD3-PerCP, anti-
TCR αβ-FITC and anti-CD25 or anti-CD45RO-PE MAbs
(BD) were used.
In a previous work we demonstrated a preferent γδ T sub-
set expansion between 7 and 10 days of PBMC culture
Table 1: Characteristics of cystic fibrosis patients included in the study
Patients Age Mutations History of infections PA culture Shwachman score Additional Data
MGV 15 ∆F508/∆F508 PA chronic colonization Pos 95
MGP 14 ∆F508/∆F508 PA chronic colonization, occasional SA Pos 76
AAS 17 ∆F508/? PA chronic colonization Pos 60
AGH 15 ∆F508/? PA chronic colonization Pos 80
MCC 14 ∆F508/? SA and PA chronic colonization Pos 65 DMID
LGS 5 ∆F508/∆F508 PA chronic colonization Pos 85
EML 29 R347H/∆F508 PA chronic colonization Pos 55
DNP 12 ∆F508/2789+ 563A PA chronic colonization Pos 95
YML 23 R347H/∆F508 PA chronic colonization Pos 55
MVG 8 ∆F508/∆F508 occasional SA Neg 90
VMM 8 ∆F508/G542X # Neg 85
ASA 7 ∆F508/L206W SA chronic colonization, occasional HI Neg 95
GCF 10 ∆F508/∆F508 occasional SA Neg 85
MSP 21 ∆F508/? * PA chronic colonization * 71 DMID
PA: Pseudomonas aeruginosa, SA: Staphylococcus aureus, HI: Haemophilus influenzae. Pos: sputum culture positive for PA, Neg: sputum culture negative 
for PA, DMID:Diabetes mellitus insulin-dependent. # PA colonization until 2 years before blood extraction, negative from this date until now * PA 
negative only for one year, blood extraction was made during this year Schwachman score rates severity based on history, physical examination and 
chest roentgenogramRespiratory Research 2003, 4 http://respiratory-research.com/content/4/1/9
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with a PA cytosolic extract [9]. In the current study γδ T
cells phenotype was determined, by three-color flow
cytometry, before and after 8 days of culture. 2500 γδ T
cells were acquired and analysed in dot-plot cytograms.
Anti-TCRγδ-PE from Immunotech (Marseille. France),
anti-CD8-PerCP and anti-CD4-FITC (BD) or either anti-
Vγ9 or anti-Vδ2-FITC from Immunotech were used.
PBMC Proliferation
PBMC (2 × 105 / well) from controls and patients were
cultured with PAc (50 µg/ml) or Phytohemaglutinin
(PHA) at 1 µg/ml (GIBCO BRL. Eragny. France), in RPMI-
1640 supplemented with 10% heat-inactivated autolo-
gous serum, for 6 and 3 days respectively. Cells were
pulsed with 1 µCi [3H]-thymidine (Amersham, UK) for 16
h.
Stimulation index (SI) was calculated by the quotient
between counts per minute (c.p.m.) obtained with and
without stimulus.
Intracellular cytokine production in response to P. 
aeruginosa and restimulation with Phorbol 12-Myristate 
13-Acetate plus Ionomicine
The activation of γδ and αβ T lymphocytes with PAc pro-
duced only low intracytoplasmic cytokine signals. Phor-
bol 12-Myristate 13-Acetate (PMA) plus Ionomicine (Io)
has been described as non distorting, policlonal stimulus,
for previously expanded antigen-specific T cells [30–32].
In the current work we determined the percentage of γδ
and αβ cytokine-producing cells at day 10 of PBMC cul-
ture with PA cytosolic extract, after restimulation with
PMA-Io. On this day, the γδ subset reached a maximal
expansion without excessive cellular death. Measurement
of single cell intracellular cytokines allowed us to deter-
mine the kind of produced cytokines and which T sub-
population was their source. This system avoided the
purification of a minor T subset, as the γδ-positive, that
could require an excessive amount of blood sample, not
available from children patients.
PBMC in complete medium (2 × 106/well) were incu-
bated with PAc (50 µg/ml) as above described. Cells were
harvested on day 10, washed and left 23 h. in culture
medium, without stimulus, at 106 cells/well. BFA (10 µg/
ml), PMA (25 ng/ml) and Io (1 µg/ml) was added for 4 h.
at 37°C, 5% CO2 in air. After washing, cells were incu-
bated for 15 min at room temperature with MAbs: anti-
TCRγδ-1-FITC (BD) or PE-conjugated (Immunotech) and
anti-CD3-PerCP (BD), fixed with FACS Lysis Solution
(BD) and washed. The pellet was incubated with 200 µl of
FACS Permeabilizing Solution (BD) for 10 min, washed
and incubated for 30 min. at room temperature with
either the anti-cytokine monoclonal antibody: anti-IL-2,
anti-IL-4-PE (BD), anti-TNF-α-PE (CALTAG. Burlingame,
CA) or anti-IFN-γ-FITC from Serotec (Oxford, England).
The cells were then washed and resuspended with 100 µl
of 1% paraformaldehide.
Samples were acquired and analysed using CellQuest soft-
ware (BD). Ten-thousand T lymphocytes were acquired
according to CD3 expression. The percentage of cytokine-
positive cells within each subset, γδ-positive or negative
was calculated. Irrelevant, isotype-matched antibodies
were used in parallel with all experimental samples.
Statistical analysis
For means comparison between two different groups and
between paired samples, the two tailed Student t or the
Mann-Whitney U test was used. For means comparison
between three groups (Controls, CFp and CFn) oneway
ANOVA and LSD PostHoc or the Kruskal-Wallis test were
used. Data are given as mean ± standard error of the mean,
p values are two-sided and considered significant when
<0.05. The calculations were performed using SPSS 6.0
software.
Results
Activation kinetics and phenotypic studies
The percentage of γδ-positive T lymphocytes before PBMC
culture was significantly higher in CFw (14.7 ± 2.4) than
in controls (5.8 ± 0.9), p < 0.01. During culture with PAc
γδ percentage first sligthly decreased, but from day 4 it
progressively increased in all groups and there were no
differences between groups (Fig 1).
Most of γδ T lymphocytes were Vγ9Vδ2 before and after
culture. The percentages of Vγ9+ and Vδ2+ cells were sig-
nificantly higher at the end than at the beginning of cul-
ture in CFw, CFp and in controls (Table 2). CFn showed
higher values of Vγ9+ and Vδ2+ at the end than before cul-
ture but without statistical significance, probably due to
the low number of individuals. Before and during culture,
few cells expressed CD8 and very few expressed CD4 in all
groups. There were no significant differences in γδ T cells
phenotype between patients and controls.
The percentage of CD25-positive γδ T cells was negligible
on day 0 but experienced an important increase after 4
days of culture, prior γδ expansion. From day 6 to 8 it
reached a maximum, over 50% of cells. A higher percent-
age of CD25-positive αβ than γδ was found at the begin-
ning of culture in controls (p < 0.001), CFp and CFn (p <
0.05), but the increase during the culture was higher in γδ
T cells. In consequence the percentage of CD25-positive
cells was higher in the γδ subset on days 6 (controls: p <
0.001, CFp: p = 0.001, CFn: not significant) and 8 (con-
trols: p < 0.05, CFp: p < 0.001, CFn: not significant) (Fig
2) and corresponded to their preferent expansion.Respiratory Research 2003, 4 http://respiratory-research.com/content/4/1/9
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The αβ CD25 expression at the end of culture (day 8) was
higher in controls than in CFp (p < 0.05) and CFn (not
significant), but there were no differences in the γδ CD25
expression between groups (Fig 2).
Before culture, the percentage of γδ CD45RO-positive cells
was significantly higher in CFw (78.9 ± 3.2) than in con-
trols (62.7 ± 5.6) (p < 0.05). When we separated patients
into CFn and CFp groups, the difference was not
significant (Fig 3). After day 4 there were no significant
differences between CFw and controls, due to the increase
Percentage of γδ positive cells in CD3-positive lymphocytes after 0, 4, 6, 8 and 10 days of PBMC culture with cytosolic extract  from Pseudomonas aeruginosa (PA) Figure 1
Percentage of γδ positive cells in CD3-positive lymphocytes after 0, 4, 6, 8 and 10 days of PBMC culture with 
cytosolic extract from Pseudomonas aeruginosa (PA). Surface expression of γδ receptor was detected in 2500 gated T 
lymphocytes, by three color cytometry, in controls (n = 17), Cystic fibrosis patients infected by PA (CFp, n = 9) and Cystic 
fibrosis patients not infected by PA (CFn, n = 4). Bar values correspond to mean ± standard error of the mean. (*) significant 
difference between controls and CFp, (**) significant difference between controls and CFn (ANOVA, LSD PostHoc test).
Table 2: Phenotypic characteristics of γδ T cells before and after 8 days of culture with cytosolic extract from P. aeruginosa (PA)
Vγ9 day 0 Vγ9 day 8 Vδ2 day 0 Vδ2 day 8 CD4 day 0 CD4 day 8 CD8 day 0 CD8 day 8
Controls 84.71 ± 3.12** 92.85 ± 1.70 77.67 ± 3.8* 89.46 ± 3.43 2.03 ± 0.93 0.76 ± 0.65 11.92 ± 2.55 10.13 ± 1.91
CFw 89.83 ± 2.78* 94.75 ± 2.06 84.65 ± 3.89* 92.39 ± 3.23 0.49 ± 0.26 0.27 ± 0.18 9.21 ± 1.17 10.13 ± 1.91
CFp 92.52 ± 1.40** 96.82 ± 1.14 85.90 ± 3.88** 94.44 ± 2.72 0.78 ± 0.37 0.54 ± 0.31 9.48 ± 1.80 9.84 ± 2.69
CFn 82.80 ± 8.8 87.45 ± 7.98 79.46 ± 10.32 87.32 ± 8.64 0.1 ± 0.01 0.1 ± 0.01 8.41 ± 1.53 11.28 ± 3.42
Results are expressed as the percentage of positive cells (mean ± s.e.m.) in the γδ T subpopulation. CFw (cystic fibrosis patients, n = 14), CFp (cystic 
fibrosis patients infected by PA, n = 8), CFn (cystic fibrosis patients without PA, n = 4). Means comparison between paired samples (days 0 and 8) 
were made by the Student's t test: *Significantly lower than the value at day 8: p < 0.01 **Significantly lower than the value at day 8: p < 0.05Respiratory Research 2003, 4 http://respiratory-research.com/content/4/1/9
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Percentage of CD25-expressing cells in αβ T lymphocytes (top) and γδ T lymphocytes (bottom), after 0, 4, 6 and 8 days of  PBMC culture with cytosolic extract from Pseudomonas aeruginosa Figure 2
Percentage of CD25-expressing cells in αβ T lymphocytes (top) and γδ T lymphocytes (bottom), after 0, 4, 6 
and 8 days of PBMC culture with cytosolic extract from Pseudomonas aeruginosa. Surface expression of CD25 (α 
chain of IL-2 receptor) was detected, by three color cytometry, in 2500 gated T lymphocytes from controls (n = 17), Cystic 
fibrosis patients infected by PA (CFp, n = 9) and Cystic fibrosis patients not infected by PA (CFn, n = 4). Bar values correspond 
to mean ± standard error of the mean. (top) αβ T lymphocytes: (*) significant difference between controls and CFp (ANOVA, 
LSD PostHoc test). (bottom) γδ T lymphocytes: significant differences were not found between groups.Respiratory Research 2003, 4 http://respiratory-research.com/content/4/1/9
Page 7 of 14
(page number not for citation purposes)
in the control group. CD45RO expression was always sig-
nificantly higher in γδ than in αβ, agreeing with other
reports [33], in controls: p < 0.05 on day 0 and p < 0.001
during culture, in CFp: p < 0.001 on day 0 and during cul-
ture and in CFn: p < 0.05 on day 0 and during culture (Fig
3).
The percentage of αβ CD45RO-positive before culture was
higher, but not significantly different in controls (45.54 ±
3.9) than in CFw (37.4 ± 2.06). Following stimulation
with PAc it increased only in the former group. At day 8,
controls had significantly higher results than CFp (p <
0.01) and CFn (p < 0.05).
PBMC Proliferation
Statistically significant differences between patients and
controls were only found for SI in response to PA. They
were higher in controls: 67.7 ± 37.8 than in CFw: 14 ± 5.4
(Mann-Whitney U test, p < 0.05). When patients were sep-
arated depending on PA infection, the differences were
not significant (Fig 4).
Intracellular cytokine production in response to P. 
aeruginosa and PMA/Io restimulation
The frequency of cytokine-producing cells within both T-
cell subsets was found in the order of TNF-α>IFN-γ>IL-2
(Fig 5). The percentage of IL-4-producing cells was in all
cases negligible.
There were no significant differences between controls
and CFw, or between controls, CFp and CFn groups, but
γδ T cells from CFp showed higher TNF-α and IFN-γ values
than controls and CFn (Fig 5).
We detected higher IFN-γ production in γδ T cells, in com-
parison to αβ, in CFw, γδ: 36.9 ± 8.4; αβ: 10.3 ± 2.5 (p <
0.01) and in controls, γδ: 30.6 ± 6.7; αβ: 15.5 ± 5.1 (p =
0.001). The same was found for TNF-α in CFw, γδ: 47.4 ±
7.4; αβ: 25.5 ± 4.8 (p = 0.001) and in controls, γδ: 47.9 ±
8.1; αβ: 20.2 ± 3.7 (p < 0.001). When we considered CFp
and CFn separately, the statistical significance only
remained in CFp, however IFN-γ and TNF-α results were
also higher in γδ than in αβ from CFn (Fig 5).
The percentage of cytokine-producing cells, αβ or γδ-pos-
itive, in total T lymphocytic population was calculated
(Fig 6). Both subsets contributed to the same extent in the
percentage of IFN-γ and TNF-α-positive lymphocytes. In
contrast, the highest number of IL-2-producing lym-
phocytes always proceeded from the αβ subset. Again, we
did not find significant differences between groups.
Correlation with clinical status
No differences were found in cytokine secretion, activa-
tion markers and PBMC proliferation in relation to clini-
cal severity of patients (data not shown).
Discussion
The present study is the first, to our knowledge, that deter-
mines the "in vitro" intracytoplasmic cytokine response to
Pseudomonas aeruginosa (PA) in αβ and γδ T lymphocytes.
We first expanded PA-reactive T cells for 10 days and then
we restimulated them with PMA-Io. The cytokine-produc-
ing frequencies among αβ and γδ T cells were found in this
order: TNF-α>IFN-γ>IL-2, for both subsets. Our results
indicate that despite recognizing different antigens from
PA [9], αβ and γδ T cells have a similar profile of cytokine
secretion, but PAc stimulation induce more γδ than αβ
IFN-γ and TNF-α-positive cells. αβ and γδ contribution to
the percentage of IFN-γ and TNF-α-producing cells in total
T lymphocytic population was the same although the αβ
subset was always predominant.
Cytokine production by αβ and γδ T lymphocytes on stim-
ulation with mycobacteria preparations and its purified
phosphoantigens has been previosly studied. The secre-
tion profile was limited to Th1-type cytokines [24,25,34–
36]. One study compared cytokine levels in supernatants
of αβ and γδ purified cells cultured with live Mycobacte-
rium tuberculosis [25] and concluded that γδ T cells were
more efficient producers of IFN-γ.
These and our present findings reinforce the evidence of
an important role for γδ T lymphocytes in the response to
bacteria through IFN-γ secretion [21]. Furthermore, an "in
vivo" γδ T memory response, already suggested in humans
[37] has been recently described in BCG-vaccinated
macaques [26]. This opens the way to new immunization
strategies.
On the other hand, our findings did not support the
hypothesis that there is a bias in CF T lymphocytes func-
tion toward a Th2 response [17,23]. There are
contradictory reports in this field. Agreement exists about
the protective role of the cellular response to PA [15–17]
but the kind of cytokines responsible for a good or a del-
eterious response in CF is still not elucidated. Some
authors demonstrate a beneficial role of the inflammatory
cytokine IFN-γ [17] and others implicate a defective pro-
duction of IL-10 in the pulmonary lesions of CF patients
[4]. Moss et al [38], found a lower IFN-γ secretion by CD4-
positive T cells in CF patients but the stimulus (anti-CD3
plus PMA) and the tested subpopulation differed from
ours.
In a previous work [8] we demonstrated a significant
increase of peripheral blood γδ T lymphocytes in cysticRespiratory Research 2003, 4 http://respiratory-research.com/content/4/1/9
Page 8 of 14
(page number not for citation purposes)
Percentage of CD45RO-expressing cells in αβ T lymphocytes (top) and γδ T lymphocytes (bottom), after 0, 4, 6, and 8 days of  PBMC culture with cytosolic extract from Pseudomonas aeruginosa Figure 3
Percentage of CD45RO-expressing cells in αβ T lymphocytes (top) and γδ T lymphocytes (bottom), after 0, 4, 
6, and 8 days of PBMC culture with cytosolic extract from Pseudomonas aeruginosa. Surface expression of 
CD45RO (memory/activation marker) was detected, by three color cytometry, in 2500 gated T lymphocytes from controls (n 
= 17), Cystic fibrosis patients infected by PA (CFp, n = 9) and Cystic fibrosis patients not infected by PA (CFn, n = 4). Bar val-
ues correspond to mean ± standard error of the mean. (top) αβ T lymphocytes: (*) significant difference between controls and 
CFp, (**) significant difference between controls and CFn (ANOVA, LSD PostHoc test). (bottom) γδ T lymphocytes: significant 
differences were not found between groups.Respiratory Research 2003, 4 http://respiratory-research.com/content/4/1/9
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PBMC Proliferative response (3H-thymidine incorporation), expressed as c.p.m. (top) and stimulation index (bottom), after cul- ture either with cytosolic extract from Pseudomonas aeruginosa (PAc) for 6 days or with Phytohemaglutinin (PHA) for 3 days Figure 4
PBMC Proliferative response (3H-thymidine incorporation), expressed as c.p.m. (top) and stimulation index 
(bottom), after culture either with cytosolic extract from Pseudomonas aeruginosa (PAc) for 6 days or with 
Phytohemaglutinin (PHA) for 3 days. Significant differences were not found between controls (n = 10), Cystic fibrosis 
patients infected by PA (CFp, n = 9) and Cystic fibrosis patients not infected by PA (CFn, n = 4), (Kruskal-Wallis test) Bar val-
ues correspond to mean ± standard error of the mean.Respiratory Research 2003, 4 http://respiratory-research.com/content/4/1/9
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Percentage of intracytoplasmic cytokine-producing cells within αβ T cells (top) and γδ T cells (bottom) after 10 days of culture  with cytosolic extract from Pseudomonas aeruginosa, followed by 4 hs restimulacion with PMA-Io Figure 5
Percentage of intracytoplasmic cytokine-producing cells within αβ T cells (top) and γδ T cells (bottom) after 10 
days of culture with cytosolic extract from Pseudomonas aeruginosa, followed by 4 hs restimulacion with PMA-
Io. Intracytoplasmic cytokine expression was detected, by three color cytometry, in 10000 gated T lymphocytes. Column val-
ues correspond to mean, bar values correspond to standard error of the mean. Significant differences were not found between 
groups (ANOVA). p values were obtained from means comparison between αβ and γδ T lymphocytes within each group: con-
trols (n = 17), Cystic fibrosis patients infected by PA (CFp, n = 9) and Cystic fibrosis patients not infected by PA (CFn, n = 4) 
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Percentage of intracytoplasmic cytokine-producing αβ T cells (top) and γδ T cells (bottom) within total T lymphocytes after 10  days of culture with cytosolic extract from Pseudomonas aeruginosa, followed by 4 hs restimulation with PMA-Io Figure 6
Percentage of intracytoplasmic cytokine-producing αβ T cells (top) and γδ T cells (bottom) within total T lym-
phocytes after 10 days of culture with cytosolic extract from Pseudomonas aeruginosa, followed by 4 hs restim-
ulation with PMA-Io. Intracytoplasmic cytokine expression was detected, by three color cytometry, in 10000 gated T 
lymphocytes. Column values correspond to mean, bar values correspond to standard error of the mean. Significant differences 
were not found between groups (ANOVA). p values were obtained from means comparison between αβ and γδ T lym-
phocytes within each group: controls (n = 17), Cystic fibrosis patients infected by PA (CFp, n = 9) and Cystic fibrosis patients 
not infected by PA (CFn, n = 4) (Student t test for paired samples).Respiratory Research 2003, 4 http://respiratory-research.com/content/4/1/9
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fibrosis patients. In later work we showed an "in vitro"
preferent  γδ T cells proliferation in response to small
cytoplasmic phosphorilated non-peptidic compounds
from PA, in healthy individuals [9]. Our present results
show that the percentage of γδ-positive cells in total T lym-
phocytes increases to the same extent in healthy and CF
individuals after PBMC culture with PAc. In both groups
the expanded subset of γδ cells, was Vγ9+Vδ2+CD4-CD8-
, already described as predominant in peripheral blood
[39,40] and reactive to ubiquitous bacterial phosphori-
lated compounds [41,42]. In contrast, this subset was
reported as not responsive to bacterial phosphoantigens
in patients with active pulmonary tuberculosis in compar-
ison to normal PPD+ subjects [14].
In the current study we have not found differences
between controls and patients in CD25 and CD45RO
expression by γδ T cells after stimulation with PA. Before
culture, patients presented a higher percentage of γδ
CD45RO-positive than controls, probably due to "in
vivo" stimulation by PA or other microorganisms.
In contrast, CD25 and CD45RO expression by CF αβ T
lymphocytes was lower than in controls. Selective apopto-
sis could account for this, but we can not exclude a con-
comitant low activation-induced expression. Proliferative
response to PA was also lower in patients. Therefore,
patients are more exposed to PA but they could present a
lower percentage of αβ T lymphocytes specific to PA.
Intrinsic and PA-derived T cell defects have already been
described in CF patients and in mouse strains prone to
chronic infection by PA [5,43]. They have been attributed
to inhibitory factors produced by accessory cells or by PA.
In this study no significant differences were found
between PA-positive and PA-negative patients, although
the present work has been mainly focused on intracyto-
plasmic cytokine production. In addition, patients with
moderate and slight severity did not present differences in
comparison to patients with good or excellent status.
Therefore, Tαβ defects from CF individuals could be
related to intrinsic characteristics or to inhibitory media-
tors produced by other cells.
γδ T cells have a crucial role in protecting airway function
and integrity [6,7] but they have been also implicated in
some pathogenic cytokine disregulation and develop-
ment of airway inflammation [11]. Their cytokine produc-
tion in response to bacterial products is tightly regulated
and this regulation depends on contact with live bacteria
[44]. We postulate that in CF patients the persistent colo-
nization by PA could avoid the IFN-γ and TNF-α switch-
ing-off that develops in acute infection, when the amount
of live bacteria decreases.
Finally, this study has been done in T subsets from periph-
eral blood and further studies at pulmonary level will be
needed to elucidate if CF epithelial cells are targets of an
excessive inflammatory response mediated by γδ T
lymphocytes.
Conclusion
We have demonstrated that γδ-positive T cells from
peripheral blood are high "in-vitro" producers of IFN-γ
and TNF-α cytokines in response to P. aeruginosa. They
contribute at the same extent as the predominant αβ sub-
set to the percentage of cytokine-positive cells in total T
lymphocyte subpopulation. The only differences found in
cystic fibrosis patients have been in the αβ activation
markers expression and the PBMC proliferative response.
γδ T cells could play a crucial role in airway defense
against P. aeruginosa and their persistent activation could
contribute to the excessive lung inflammation in cystic
fibrosis patients.
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